ABSTRACT. The purpose of this study was the development and validation of an LC-MS/MS method, for the concomitant and rapid determination amoxicillin and clavulanic acid from human plasma. The sample workup involved a simple protein precipitation procedure. A core/shell type analytical column (50×2,1 mm, 2.6 Å) was used with PFP stationary phase. A mobile phase with high aqueous composition provided satisfactory separation with good accuracy and precision (stable ionization). The mass spectrometer was operated in positive electrospray ionization mode for both analytes and internal standard. The following parameters were evaluated for validation purpose: Selectivity, sensitivity, matrix effect, anticoagulant effect, linearity, precision and accuracy, recovery, analyte/IS stability in solvent/matrix and carryover. The validated calibration range was 190-22222 ng/ml for amoxicillin, and 147-4908 ng/ml for clavulanic acid. The correlation coefficient R 2 was at least 0.99 for both analytes. The validated method has been successfully used for the evaluation bioequivalence of generic amoxicillin/potassium clavulanate formulations.
INTRODUCTION

Amoxicillin (2S,5R,6R)-6-[(R)-(-)
Amoxicillin is susceptible to degradation by β-lactamases, and therefore, the activity spectrum does not include organisms which produce these enzymes [1] .
Clavulanic acid (Z)-(2R,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]-heptane-2-carboxylic acid (C 8 H 8 KNO 5 -potassium salt) is a β-lactam (Figure 2 ), produced by the fermentation of Streptomyces clavuligerus structurally related to the penicillins, which possesses the ability to inactivate a wide range of β-lactamase enzymes commonly found in microorganisms resistant to penicillins. In particular, it has good activity against the clinically important plasmid-mediated β-lactamases frequently responsible for transferred drug resistance [15] . The formulation of amoxicillin and clavulanic acid (as potassium salt) protects amoxicillin from β-lactamase enzymes degradation and effectively extends the antibiotic spectrum of amoxicillin to many bacteria normally resistant to amoxicillin and other β-lactam antibiotics. Thus amoxicillin/ clavulanic acid possesses the distinctive properties of a broad-spectrum antibiotic and a β-lactamase inhibitor [5] .
RESULTS AND DISCUSSION
Determination of acquisition parameters
There are several methods known in the literature for the individual and/or simultaneous determination of amoxicillin and clavulanic acid in human plasma and other biological matrix using UV [2, 6, 11, 13] and MS/MS methods [3] [4] [5] [7] [8] [9] 12] . All MS/MS methods involve polarity switching, for monitoring the clavulanic acid in negative electrospray ionization mode. The method developed in this study uses positive ionization mode for the detection of all entities. Even if the clavulanic acid prefers a negative ionization mode, the abundance in positive ionization mode was high enough to achieve a suitable LLOQ (Lower Limit of Quantitation).
The m/z transitions used for multiple reaction monitoring (MRM) were chosen based on the spectra from 
Bioanalytical method validation
The analytical method was validated according to the EMEA/CHMP/ EWP/192217/2009 Guideline on validation of bioanalytical methods [14] .
The tested parameters were: selectivity, sensitivity, matrix effect, anticoagulant effect, intra/interbatch precision and accuracy, recovery, short/ long term stability of stock solutions of analytes, short term stability of working solutions of analytes, bench top stability in biological matrix, freeze thaw stability in biological matrix, injector/autosampler stability of the processed samples, stability during delayed processing, dilution integrity, carryover. All tests were performed using 6 replicates at the mentioned QC (Quality Control) levels.
The validated calibration range was 190-22222 ng/ml for amoxicillin, and 147-4908 ng/ml for clavulanic acid. The calibration curves were obtained using a quadratic weighted (1/x 2 ) for Amoxicillin and quadratic weighted (1/x 2 ) for Clavulanic Acid regression analysis of the peak area ratio (analyte/internal standard) versus the nominal concentration of the calibration standards. A summary of main results of validation batches is presented in Tables 1 and 2 . 
Summary of method validation
CONCLUSIONS
A rapid and robust method has been developed and validated for the simultaneous determination of amoxicillin and clavulanic acid in human plasma. The quantitation was performed on an Agilent 1200 series HPLC system, coupled to an Agilent 6410 triple quadrupole mass spectrometer, using electrospray ionization technique. All components were detected in positive ionization mode. The method was successfully used for the evaluation of bioequivalence of a generic formulation of amoxicillin/ clavulanic acid in human subjects.
EXPERIMENTAL SECTION
Solvents and reference materials used
All used solvents are of HPLC grade. Dichloromethane (stabilized with amylene) was purchased from Riedel (Sigma), formic acid and acetonitrile from Merck KGaA, HPLC water was obtained using a Millipore Simplicity UV water purification system. Certified reference materials of amoxicillin trihydrate, potassium clavulanate and ampicillin trihydrate (internal standard-IS) were obtained from Sigma-Aldrich and are of analytical standard grade (Vetranal). Blank human plasma was obtained from the regional blood transfusion center (CRTS) Cluj.
Instrumentation and working parameters
An Agilent 1200 series HPLC system with a Phenomenex Kynetex PFP column (50 × 2.10 mm) equipped with Phenomenex Security Guard (4 ×2.0 mm) was used for separation. The used mobile phase was an isocratic mixture of 8:92 acetonitrile:water (containing 0.25% formic acid). The used flow rate was 0.3 ml/min, the column temperature was set to 38 ºC. An Agilent 6410 triple Quadrupole Mass Spectrometer (Agilent Technologies, USA), equipped with electrospray ion source was used for the LC-MS/MS analyses. The runtime was 5 min/sample. The data acquisition and processing was carried out using MassHunter software. The whole system (software and hardware) was validated. The mass spectrometer was operated in positive ionization mode for both analytes and IS. Nitrogen was used as nebulizing gas and collision cell gas. The temperature of the ESI source was set to 350 ºC, and the needle voltage to 4000V.
The quantitation was performed using MRM (multiple reaction monitoring) of the transitions: m/z 366. The mass spectrometer was operated at unit resolution with a dwell time of 300 ms per transition.
Stock and working solutions preparation
Stock solutions were prepared in ultrapure water dissolving accurately weighed amounts of reference materials, at 1.7 mg/ml -amoxiclillin and 1 mg/ml K clavulanate and ampicillin. They were stored between 2-8 °C.
Working solutions of analytes and internal standard were prepared freshly before use by successive dilutions from stock solutions to appropriate levels, using water as solvent. They were used for spiking in human plasma used for calibrators and QC samples preparation. 
Calibrators and QC samples preparation
Sample preparation (workup)
To precipitate proteins, 1500 µl of acetonitrile was added to the spiked samples, then vortexed for 20 minutes at 1500 rpm. Further the samples were centrifuged for 10 minutes at 4000 rpm. 1750 µl of supernatant was transferred into a new test tube. 1500 µl of ultrapure water and 5000 µl of dichloromethane were added and the samples were vortexed for 5 minutes at 1500 rpm. To accelerate phase separation samples were centrifuged for 10 minutes at 4000 rpm. Finally 800 µl of the resulting supernatant were transferred to HPLC autosampler vials and injected into the analytical system (15 µl/sample).
The novelty of the method is the extraction of acetonitrile from the aqueous mixture with dicloromethane which was meant to reduce the organic content of the samples as much as possible without evaporation. In this way the organic content of the samples was close to the composition of the mobile phase, giving a better peakshape of the chromatograms. Furthermore, the presence of high amounts of acetonitrile in the samples acts inhibitory on the ionization of clavulanic acid in positive acquisition mode. The used docloromethane was stabilized with amylene (ethanol stabilized dichloromethane should not be used, because alcohol promotes the decomposition/hydrolysis [10] of the β-lactam ring in penicillin class antibiotics).
Calibration curve parameters
The linearity of the method was evaluated using spiked plasma samples in the concentration range mentioned above using the method of least squares. Three linearity curves were analyzed.
Each calibration batch (curve) consisted of: blank samples in duplicate, zero samples (blank with IS) in duplicate and eight non-zero concentration levels, of which the lower and upper limit of quantitation samples were in duplicate. The calibration curves were obtained by using a quadratic weighted (1/x 2 ) for Amoxicillin and quadratic weighted (1/x 2 ) for Clavulanic Acid regression analysis of the peak area ratio (analyte/internal standard) versus the nominal concentration of the calibration standards. Study samples concentrations were obtained by interpolation from the calibration curve.
The linearity results are summarized in Tables 3 and 4 in the 'Results and Discussion' section.
